2nd Quarter - Report

CENCORA, INC. for CENCORA, INC.

Firm
Client
Income
—
Expenses
$760,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Ensuring Community Access to Pharmacist Services Act (H.R. 3164) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Extend payment increase under Medicare's physician fee schedule. Medicare Access & CHIP Reauthorization Act (MACRA). Physician Medicare reimbursement annual fee update. Protecting Patient Access to Cancer and Complex Therapies Act 2025 Reimbursement policies impacting drug shortages Part B drug pricing changes Enhanced Oncology Model (EOM) Preventing and Mitigating Generic Drug Shortages

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 3164 (119th)

Pharmacy PHA

Preventing and Mitigating Generic Drug Shortages Ensuring Seniors Access to Critical Medications Act (H.R. 3164) Impacts to pharmacy Part D drug pricing in IRA

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3164 (119th)

Health Issues HCR

Strategic National Stockpile. Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Drug Shortages Pandemic and All Hazards Preparedness Reauthorization and Response Act (legislation). SUPPORT Act Reauthorization Medical Supply Resiliency Act National Defense Authorization Act (NDAA) Supply Chain Resiliency Budget Reconciliation Most Favored Nation drug pricing proposals

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 4132 (119th), S. 2027 (119th)

Taxation/Internal Revenue Code TAX

One Big Beautiful Bill Act (H.R.1) Tariff proposed policies LIFO accounting method Global Intangible Low-taxed Income (GILTI)

LobbyistCovered position, as disclosed
VIVIENNE STAFFORD MITCHELL —
SHELLY MUI-LIPNIK —
DARRELL ROGERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.